1106 / 1816
Whole cohort
No pCR
Molecular subtypes, residual disease and 5-yr LRR
Conclusion:
TN breast cancer pts have a poor prognosis, and in particular patients with no
pCR have a very high LRR risk
Patients with HR+ or HER2+ breast cancer had favourable LRR rates regardless
of NAC response
In addition: the National Comprehensive Cancer Network (NCCN) and St. Gallen
consensus statements advise to use the pre-NAC staging and risk factors